Man Industries (India) Ltd. - Research Center
513269 MANINDS Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 924.76 | 1,200.19 | 893.89 | 985.57 | 1,214.21 |
| Operating profit | 36.39 | 99.98 | 79.97 | 96.06 | 116.93 |
| Interest | 18.37 | 20.22 | 17.08 | 33.20 | 37.53 |
| Gross profit | 32.68 | 99.48 | 80.35 | 82.52 | 77.09 |
| EPS (Rs) | 0.67 | 9.83 | 7.54 | 7.80 | 7.29 |
Half yearly
results in details
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 14.66 | 19.72 | 17.46 | 19.66 | -2.31 |
| Stock adjustment | 82.29 | -15.35 | 0.51 | 19.31 | 57.16 |
| Raw material | 593.86 | 873.10 | 619.08 | 639.67 | 776.69 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 29.49 | 27.25 | 25.86 | 26.49 | 28.02 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 182.73 | 215.21 | 168.47 | 204.04 | 235.41 |
| Provisions made | - | - | - | - | - |
| Depreciation | 22.76 | 22.89 | 22.33 | 23.40 | 28.06 |
| Taxation | 5.91 | 18.42 | 14.97 | 14.56 | 4.91 |
| Net profit / loss | 4.01 | 58.17 | 43.05 | 44.56 | 41.62 |
| Extra ordinary item | - | - | - | - | -2.50 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 30.05 | 29.59 | 28.55 | 28.55 | 28.55 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 3.94 | 8.33 | 8.95 | 9.75 | 9.63 |
| GPM (%) | 3.48 | 8.15 | 8.82 | 8.21 | 6.36 |
| NPM (%) | 0.43 | 4.77 | 4.72 | 4.43 | 3.43 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis